Henan Zhongshuai Medical Technology Co., Ltd., formerly known as Henan Zhongshuai Medical Technology Development Co., Ltd., was established in 2001. Since its establishment, the company has always adhered to the business philosophy of "people-oriented, pragmatic and innovative, serving the society and contributing high-quality products" and the enterprise spirit of "honesty, efficiency and innovation". With scientific management mode, advanced production technology and complete testing equipment, the company focuses on the R & D and registration of drugs with clinical value. At present, the total number of new slow and controlled release drugs accepted by SFDA is in a leading position among pharmaceutical enterprises in the whole province and even the whole country. It has gradually created a high popularity inside and outside the province and has become a well-known brand in drug development and technical services in Henan Province. The company's development strategy is to "build two platforms and expand one disease treatment field", "two platforms" refer to "R & D technology platform in Zhengzhou" and "industrialization base platform in Anyang", and "one disease treatment field" refers to "drug treatment field of attention deficit hyperactivity disorder". "R & D technology platform" is the most important cornerstone of the company's core competitiveness and undertakes the tasks of drug innovation and service outsourcing; The construction of "Anyang industrialization base platform" promotes the company to move steadily towards the industrialization of independent property rights R & D projects. As an important support for the company's future development, it will become a new growth point for the company's future development; "A disease treatment field" is a major event related to the health of Chinese people. The company takes this as its own responsibility to promote Chinese people's awareness of ADHD, improve the degree of intervention and drug treatment rate, and expand the market space for the company's future development.